Fresenius Accounts Payable from 2010 to 2024

FMS Stock  USD 22.02  0.46  2.05%   
Fresenius Medical Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable will likely drop to about 545.6 M in 2024. Accounts Payable is the amount Fresenius Medical Care owes to suppliers or vendors for products or services received but not yet paid for. It represents Fresenius Medical's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
1998-12-31
Previous Quarter
784 M
Current Value
868.2 M
Quarterly Volatility
256.6 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as Interest Expense of 238.5 M, Total Revenue of 11.4 B or Gross Profit of 3.7 B, as well as many indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.0612 or PTB Ratio of 0.39. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
  
Check out the analysis of Fresenius Medical Correlation against competitors.

Latest Fresenius Medical's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Fresenius Medical Care over the last few years. An accounting item on the balance sheet that represents Fresenius Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Fresenius Medical Care are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Fresenius Medical's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fresenius Medical's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Fresenius Accounts Payable Regression Statistics

Arithmetic Mean668,390,450
Geometric Mean615,740,266
Coefficient Of Variation31.75
Mean Deviation171,457,216
Median737,842,000
Standard Deviation212,221,351
Sample Variance45037.9T
Range765.2M
R-Value0.70
Mean Square Error24440.2T
R-Squared0.50
Significance0
Slope33,424,137
Total Sum of Squares630530.6T

Fresenius Accounts Payable History

2024545.6 M
2023839.1 M
2022892.6 M
2021818.5 M
2020827.4 M
2019835.2 M
2018795.1 M

About Fresenius Medical Financial Statements

Fresenius Medical shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Fresenius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable839.1 M545.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.